查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2016310

安全注射器市場：按材料、注射器容量、應用、最終用戶和分銷管道分類－2026-2030年全球市場預測

Safety Syringes Market by Material, Syringe Volume, Application, End User, Distribution Channel - Global Forecast 2026-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年安全注射器市值為 73.2 億美元，預計到 2025 年將成長至 77 億美元，複合年成長率為 5.29%，到 2030 年將達到 99.8 億美元。

主要市場統計數據
基準年 2024 73.2億美元
預計年份：2025年 77億美元
預測年份 2030 99.8億美元
複合年成長率 (%) 5.29%

探討安全注射器在現代醫療保健服務體系和病人保護框架中的基本重要性和發展演變。

隨著對病人和醫護人員安全的日益重視，醫療服務格局正在發生不可逆轉的改變，安全注射器已成為現代臨床實踐中不可或缺的組成部分。人們對針刺傷和血液傳播病原體的擔憂日益加劇，促使全球醫療系統實施了日益嚴格的規程。這項轉變的驅動力既來自技術進步，也來自旨在保護第一線醫護人員和病患的健全法規結構。因此，安全注射器已從一種小眾的專業產品轉變為醫院、門診診所和居家醫療服務中的主流必需品。

近期的技術創新、政策趨勢和臨床實踐檢驗正在重新定義整個醫療保健環境中注射器的使用和安全標準。

近年來，在最尖端科技和不斷變化的監管要求的推動下，安全注射器領域發生了翻天覆地的變化。自動失效機制和針頭儲存系統已成為關鍵創新，有效減少了意外針刺傷和未經授權的重複使用。同時，嵌入式RFID標籤和條碼掃描等數位追蹤功能的整合，提高了整個供應鏈的可追溯性，從而促進了更高水準的品管和庫存管理。

對美國新徵收的關稅對安全注射器產業的供應鏈、生產成本和戰略採購決策的影響進行評估。

美國在2025年實施的新進口關稅使全球安全注射器供應鏈更加複雜，對聚合物樹脂和玻璃零件的採購都產生了影響。嚴重依賴進口玻璃管的製造商面臨越來越大的成本壓力，被迫重新評估其原料籌資策略。同樣，高精度塑膠注射器筒體和活塞的製造商也因關稅而面臨利潤率下降的困境，迫使他們與供應商進行談判，或在某些情況下考慮轉向國內生產。

按材料、產能、應用、最終用戶和分銷管道分類的詳細細分市場展望，這些因素塑造了市場動態和機會。

市場區隔洞察揭示了驅動產品開發和商業化策略的微妙動態，這些動態涵蓋材料、容量、應用、終端用戶和分銷管道等諸多方面。材料選擇對性能和成本有顯著影響；玻璃注射器因其化學惰性和尺寸精度而備受青睞，而塑膠注射器則具有更優異的易用性、抗衝擊性和更低的單位成本。同時，容量分類決定了臨床適用性。容量小於 5 毫升的小型注射器用於常規給藥和取樣操作，容量為 6 至 10 毫升的中型注射器適用於特殊治療，而容量大於 10 毫升的大型注射器則支援大容量液體輸注。

為了確定安全注射器的戰略成長模式和影響因素，我們分析了美洲、歐洲、中東和非洲以及亞太地區的區域特徵。

區域分析凸顯了美洲、歐洲、中東和非洲以及亞太地區截然不同的成長軌跡和應用促進因素。在美洲，嚴格的安全法規和健全的報銷機制推動了先進注射器技術的廣泛應用。居家醫療模式的建立和疫苗接種工作的開展進一步刺激了需求，迫使供應商在易用性和供應可靠性方面進行創新。

對推動安全注射器解決方案發展的關鍵產業參與者的策略性舉措、技術合作和競爭優勢進行評估。

安全注射器市場的主要企業透過在研發、全球製造地和有針對性的合作夥伴關係方面的策略投資來脫穎而出。貝克頓·迪金森公司正在擴展其可伸縮系統產品夥伴關係，優先發展智慧標籤解決方案以增強可追溯性。Terumo Corporation持續改進注射技術，專注於人體工學改進和與自動化藥物分發系統的兼容性。可伸縮技術公司致力於研發創新安全針頭機制並保護智慧財產權，以增強其競爭優勢。

明確策略挑戰、營運改善和合作途徑，以支持產業領導者推動安全注射器的創新和應用。

為了保持競爭優勢並應對新興市場的複雜性，產業領導者應考慮以下幾個策略挑戰。首先，優先研發並推出新一代可伸縮機構，既能實現產品線差異化，又能滿足日益嚴格的安全法規要求。其次，透過多供應商合約和本地化生產建立具有韌性的供應鏈，可以減輕外部關稅造成的供應中斷和物流限制。

我們提出了一套嚴謹的資料收集方法、分析框架和檢驗方法，這些方法支撐了我們對安全注射器產業分析的可靠性。

我們的分析架構透過嚴格結合二手資料研究、專家訪談和資料檢驗流程，確保了研究的全面性和可靠性。首先，我們仔細審查了歷史監管文件、產品技術規範和政策白皮書，以建立對安全注射器監管要求和性能標準的基礎理解。除了這些二手資料研究之外，我們還與臨床醫生、採購負責人和行業工程師進行了深入訪談，以了解推動產品應用和營運挑戰的定性見解。

將對市場趨勢、監管影響、細分趨勢和區域機會的洞察融入其中，將指導未來對安全注射器技術的投資。

在安全期望不斷提高、技術進步和監管環境不斷變化等因素的推動下，注射式醫療器材解決方案迎來了新時代。詳細的細分市場分析表明，材料選擇、容量規格和應用特定設計在滿足臨床和居家醫療環境的多樣化需求方面都發揮著至關重要的作用。區域性洞察進一步強調了根據當地法規結構、成本結構和不斷發展的醫療保健服務模式調整策略的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 安全注射器市場：依材料分類

  • 玻璃
  • 塑膠

第9章：以注射器容量分類的安全注射器市場

  • 6～10 mL
  • 超過10毫升
  • 5毫升或更少

第10章 安全注射器市場：依應用領域分類

  • 藥物管理
    • 不可伸縮型 - 給藥
    • 可伸縮式－用於給藥
  • 疫苗接種
    • 不可伸縮型疫苗接種
    • 可伸縮型 - 疫苗接種
  • 胰島素給藥
    • 不可回縮式胰島素給藥
    • 可伸縮式 - 胰島素注射
  • 檢體採集和診斷
    • 非伸縮式－檢體採集與診斷
    • 可伸縮式－檢體採集與診斷

第11章 安全注射器市場：依最終使用者分類

  • 門診手術中心
  • 診斷檢查室
  • 居家醫療
  • 醫院和診所

第12章 安全注射器市場：依通路分類

  • 離線
    • 醫院藥房
    • 零售藥房
  • 線上

第13章 安全注射器市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 安全注射器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 安全注射器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國安全注射器市場

第17章 中國安全注射器市場

第18章 競爭格局

  • 2024年市場集中度分析
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2024 年
  • 2024年產品系列分析
  • 基準分析，2024 年
  • AdvaCare Pharma, LLC
  • BAUMANN Group
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Gerresheimer AG
  • Hindustan Syringes & Medical Devices Ltd
  • ICU Medical, Inc.
  • KB MEDICAL GROUP INC
  • Kindly（KDL）Group
  • Medline Industries, LP
  • Owen Mumford Ltd.
  • Retractable Technologies, Inc.
  • SCHOTT AG
  • Sol-Millennium
  • UltiMed, Inc.
Product Code: MRR-03050D1B2D6B

The Safety Syringes Market was valued at USD 7.32 billion in 2024 and is projected to grow to USD 7.70 billion in 2025, with a CAGR of 5.29%, reaching USD 9.98 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 7.32 billion
Estimated Year [2025] USD 7.70 billion
Forecast Year [2030] USD 9.98 billion
CAGR (%) 5.29%

Exploring the Fundamental Importance and Evolution of Safety Syringes within Modern Healthcare Delivery Systems and Patient Protection Frameworks

The landscape of healthcare delivery has been irrevocably transformed by the growing emphasis on patient and practitioner safety, making safety syringes an indispensable element within modern clinical practice. In response to rising concerns over needle-stick injuries and the transmission of bloodborne pathogens, healthcare systems worldwide have adopted increasingly stringent protocols. This evolution has been driven by both technological advances and robust regulatory frameworks designed to protect frontline workers and patients alike. Consequently, safety syringes have migrated from a specialized niche product to a mainstream necessity in hospitals, ambulatory centers, home healthcare services, and beyond.

As public health initiatives expand immunization programs and chronic disease management continues to rely heavily on injectable therapies, the demand for sophisticated syringe technologies has escalated. Manufacturers are now challenged to balance safety features with ergonomic design, cost efficiency, and compatibility across a diverse array of applications. The intersection of product innovation and policy enforcement has fostered a dynamic environment, compelling stakeholders to rethink traditional approaches to syringe manufacturing and distribution.

This executive summary sets the stage for a thorough exploration of the forces shaping the safety syringe market. It delves into emerging trends, tariff impacts, segmentation insights, regional dynamics, and competitive strategies. By synthesizing these dimensions, readers will acquire a clear understanding of the market's trajectory, enabling stakeholders to navigate complexities and capitalize on growth opportunities in the evolving world of injection safety.

Examining Recent Technological Innovations Policy Developments and Clinical Practices That Are Redefining the Utilization and Safety Standards of Syringe Devices Across Healthcare Environments

Recent years have witnessed transformative shifts in the safety syringe arena, propelled by cutting-edge technologies and evolving regulatory mandates. Auto-disable mechanisms and retractable needle systems have emerged as pivotal innovations, effectively minimizing accidental needle sticks and unauthorized reuse. Concurrently, integration of digital tracking features-such as embedded RFID tags and barcode scanning capabilities-has enhanced traceability throughout the supply chain, fostering higher levels of quality control and inventory management.

On the regulatory front, initiatives such as enhanced device directives in key markets and updates to pharmacopoeia standards have set rigorous benchmarks for material composition, sterilization validation, and performance testing. These developments reflect a broader industry commitment to reinforce patient safety, reduce healthcare-associated infections, and align with global sustainability objectives by promoting recyclable or lower-emission manufacturing processes.

Moreover, clinical practice adjustments-driven by large-scale immunization campaigns and the expansion of home healthcare services-have underscored the need for user-friendly, reliable syringe systems. Consequently, manufacturers and healthcare providers are collaborating to refine training protocols, optimize ergonomic features, and ensure seamless integration within existing medical workflows. These converging trends illustrate how regulatory evolution, technological breakthroughs, and shifting care models collectively reshape the safety syringe landscape.

Assessing How Newly Implemented United States Tariffs Have Influenced Supply Chains Production Costs and Strategic Sourcing Decisions in the Safety Syringe Sector

The implementation of new United States import duties in 2025 has injected complexity into the global safety syringe supply chain, affecting both polymer resin and glass component procurement. Manufacturers that rely heavily on imported glass tubes have encountered elevated cost pressures, prompting a reassessment of raw material sourcing strategies. Likewise, producers of high-precision plastic barrels and plungers have grappled with tariff-induced margins, necessitating negotiations with suppliers and, in some cases, exploring domestic production alternatives.

In response, several industry players have initiated nearshoring efforts to establish or expand onshore or nearshore manufacturing capacities. This strategic shift aims to mitigate future tariff risks, reduce lead times, and enhance supply chain resilience. Parallel to these initiatives, organizations have engaged in selective supplier diversification, forging partnerships with multiple resin and glass vendors to ensure redundancy and maintain uninterrupted production.

While the tariff landscape presents undeniable challenges, it has also catalyzed innovation in logistics and procurement. Companies are increasingly leveraging advanced forecasting tools and collaborative planning with key distributors to optimize inventory levels. As a result, the sector is experiencing a recalibration of sourcing networks that may yield long-term efficiencies and strengthen competitive positioning despite the immediate cost headwinds.

Uncovering Detailed Segmentation Perspectives by Material Volume Application End Users and Distribution Channels Shaping Market Dynamics and Opportunities

Insight into market segmentation reveals nuanced dynamics that drive product development and commercialization strategies across diverse material, volume, application, end-user, and distribution dimensions. Material considerations weigh heavily on performance and cost, with glass syringes prized for their chemical inertness and dimensional accuracy while plastic variants offer superior disposability, impact resistance, and lower per-unit expense. In parallel, volume categorization defines clinical suitability: smaller formats up to 5 milliliters serve routine drug delivery and sampling procedures, mid-range sizes between 6 and 10 milliliters accommodate specialized therapies, and larger formats exceeding 10 milliliters support bulk fluid administration.

Application segmentation further refines product profiles by focusing on distinct use cases. Drug delivery systems diverge into non-retractable and retractable designs, each tailored to practitioner ease and patient safety requirements. Immunization syringes carry similar bifurcation, optimizing needle retraction mechanisms or fixed configurations based on high-throughput vaccination settings. Insulin delivery platforms incorporate feedback cues and safety locks to address chronic care demands, and sampling & diagnostics fixtures demand precise volume measurement alongside prevention of cross-contamination through non-retractable or retractable options.

End-user insight underscores varied adoption patterns, as ambulatory surgical centers prioritize disposability and rapid turnover, diagnostic laboratories emphasize accuracy and contamination control, home healthcare channels demand user empowerment and ease of use, and hospitals and clinics focus on scalability, regulatory compliance, and integration within centralized supply systems. Finally, distribution channels shape market outreach; offline networks leverage dedicated hospital and retail pharmacy partnerships to ensure clinical availability, while online platforms expand direct-to-consumer and institutional procurement, unlocking new growth vectors.

Analyzing Regional Nuances from the Americas Europe Middle East Africa and Asia Pacific to Reveal Strategic Growth Patterns and Adoption Drivers in Safety Syringes

Regional analysis highlights distinct growth trajectories and adoption catalysts across the Americas, Europe Middle East & Africa, and Asia Pacific regions. In the Americas, stringent safety regulations and robust reimbursement frameworks underpin widespread deployment of advanced syringe technologies. The established presence of home healthcare models and vaccination initiatives further propels demand, compelling suppliers to innovate around usability and supply reliability.

Across Europe, the Middle East, and Africa, diverse regulatory landscapes present both challenges and opportunities. Western European nations maintain rigorous device directives and environmental mandates, while emerging markets in the Middle East and African subregions exhibit rising healthcare investment, expanding hospital infrastructure, and concerted efforts to enhance patient safety protocols. Consequently, multinational manufacturers often tailor product portfolios to navigate varying certification pathways and meet localized requirements.

The Asia Pacific region emerges as a critical hub for both manufacturing and consumption. Cost-sensitive markets drive demand for competitively priced plastic syringe solutions, whereas rapidly expanding immunization programs in Southeast Asia and Australia foster the adoption of retractable and auto-disable devices. Furthermore, China and India continue to strengthen their manufacturing capabilities, offering scale advantages and introducing export potential that reshapes global supply dynamics.

Evaluating Leading Industry Participants Their Strategic Initiatives Technology Partnerships and Competitive Differentiators Driving Progress in Safety Syringe Solutions

Leading participants in the safety syringe market are distinguished by their strategic investments in research and development, global manufacturing footprints, and targeted partnerships. Becton Dickinson has expanded its portfolio of retractable systems, prioritizing smart labeling solutions that enhance traceability. Terumo Corporation continues to refine its injection technologies, emphasizing ergonomic enhancements and compatibility with automated medication dispensing units. Retractable Technologies has championed innovative safety needle mechanisms, securing intellectual property that reinforces its competitive moat.

West Pharmaceutical Services has leveraged its expertise in component design to introduce high-precision plunger systems that minimize dosing variability. Schott AG's glass manufacturing excellence has positioned it as a preferred partner for premium syringe requirements, particularly where chemical resistance and dimensional consistency are paramount. Meanwhile, Vetter Pharma Services has diversified its service offerings by integrating prefilled syringe assembly with strict aseptic processing, catering to biopharmaceutical clients seeking turnkey solutions.

Collectively, these organizations demonstrate how targeted collaborations, capacity expansions, and product diversification can drive differentiation and market penetration amidst evolving safety standards and supply chain pressures.

Providing Clear Strategic Imperatives Operational Enhancements and Collaboration Pathways to Empower Industry Leaders in Advancing Safety Syringe Innovation and Accessibility

To maintain a competitive edge and address emerging market complexities, industry leaders should consider several strategic imperatives. First, prioritizing the development and deployment of next-generation retractable mechanisms will address heightened safety mandates while differentiating product offerings. Second, fostering resilient supply chains through multi-sourcing agreements and localized manufacturing can mitigate external tariff disruptions and logistical constraints.

In parallel, aligning product innovation with regulatory roadmaps-such as anticipated updates to device directives and pharmacopoeia standards-will streamline approval processes and accelerate time to market. Collaboration with healthcare providers to refine training materials and usability testing can further enhance device adoption and compliance. Additionally, customizing market approaches to regional characteristics-addressing cost sensitivities in emerging Asia Pacific markets or sustainability priorities in Europe-will optimize resource allocation and drive penetration.

Finally, exploring digital engagement channels, including e-commerce platforms and integrated devices that support remote monitoring, can unlock new channels for growth. By embedding these recommendations within their strategic plans, industry players can bolster resilience, spur innovation, and capitalize on evolving opportunities in the safety syringe domain.

Presenting a Rigorous Approach to Data Collection Analytical Frameworks and Validation Techniques Underpinning the Reliability of Our Safety Syringe Industry Analysis

Our analytical framework draws upon a rigorous blend of secondary research, expert interviews, and data validation protocols to ensure comprehensive coverage and reliability. Initially, historical regulatory documentation, technical product specifications, and policy white papers were examined to construct a foundational understanding of safety syringe mandates and performance benchmarks. This secondary layer was supplemented by in-depth conversations with clinicians, procurement specialists, and industry engineers, yielding qualitative insights into adoption drivers and operational challenges.

Key findings were triangulated through cross-referencing publicly available financial filings, patent registries, and trade publications, enabling the identification of competitive strategies and technology trajectories. Geographic and segmentation data was validated using regional health authority reports and distributor feedback, ensuring alignment with on-the-ground market realities. Throughout this process, iterative review sessions with external experts and internal analysts reinforced methodological consistency, while adherence to ethical guidelines and confidentiality agreements safeguarded proprietary information.

This multi-faceted approach provides stakeholders with a transparent, robust foundation for strategic decision-making, delivering both depth and breadth in coverage across all relevant market dimensions.

Synthesizing Insights on Market Trends Regulatory Impacts Segmentation Dynamics and Regional Opportunities to Guide Future Investments in Safe Syringe Technologies

The convergence of heightened safety expectations, advancing technologies, and shifting regulatory landscapes has established a new era for injectable device solutions. Through detailed segmentation analysis, it becomes evident that material selection, volume specifications, and application-driven design each play a critical role in meeting the diverse needs of clinical and home healthcare settings. Regional insights further underscore the importance of tailoring strategies to local regulatory frameworks, cost structures, and evolving care delivery models.

Tariff-related pressures in the United States have prompted a reevaluation of sourcing paradigms, accelerating nearshoring efforts and supplier diversification that promise to enhance supply chain resilience. Meanwhile, leading manufacturers continue to distinguish themselves through targeted R&D, strategic collaborations, and expanded service capabilities. Collectively, these developments point toward a market environment defined by innovation, agility, and a steadfast commitment to safety.

By integrating the strategic recommendations outlined herein, stakeholders can navigate complexities effectively, leveraging actionable insights to drive product differentiation, operational efficiency, and sustainable growth within the safety syringe domain.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2024
  • 3.5. FPNV Positioning Matrix, 2024
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Safety Syringes Market, by Material

  • 8.1. Glass
  • 8.2. Plastic

9. Safety Syringes Market, by Syringe Volume

  • 9.1. 6 to 10 ML
  • 9.2. Above 10 ML
  • 9.3. Upto 5 ML

10. Safety Syringes Market, by Application

  • 10.1. Drug Delivery
    • 10.1.1. Non-Retractable- Drug Delivery
    • 10.1.2. Retractable- Drug Delivery
  • 10.2. Immunization
    • 10.2.1. Non-Retractable- Immunization
    • 10.2.2. Retractable- Immunization
  • 10.3. Insulin Delivery
    • 10.3.1. Non-Retractable- Insulin Delivery
    • 10.3.2. Retractable- Insulin Delivery
  • 10.4. Sampling & Diagnostics
    • 10.4.1. Non-Retractable-Sampling & Diagnostics
    • 10.4.2. Retractable- Sampling & Diagnostics

11. Safety Syringes Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Laboratories
  • 11.3. Home Healthcare
  • 11.4. Hospitals & Clinics

12. Safety Syringes Market, by Distribution Channel

  • 12.1. Offline
    • 12.1.1. Hospital Pharmacies
    • 12.1.2. Retail Pharmacies
  • 12.2. Online

13. Safety Syringes Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Safety Syringes Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Safety Syringes Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Safety Syringes Market

17. China Safety Syringes Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2024
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2024
  • 18.3. Product Portfolio Analysis, 2024
  • 18.4. Benchmarking Analysis, 2024
  • 18.5. AdvaCare Pharma, LLC
  • 18.6. BAUMANN Group
  • 18.7. Becton, Dickinson and Company
  • 18.8. Cardinal Health, Inc.
  • 18.9. Gerresheimer AG
  • 18.10. Hindustan Syringes & Medical Devices Ltd
  • 18.11. ICU Medical, Inc.
  • 18.12. KB MEDICAL GROUP INC
  • 18.13. Kindly (KDL) Group
  • 18.14. Medline Industries, LP
  • 18.15. Owen Mumford Ltd.
  • 18.16. Retractable Technologies, Inc.
  • 18.17. SCHOTT AG
  • 18.18. Sol-Millennium
  • 18.19. UltiMed, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SAFETY SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 2. GLOBAL SAFETY SYRINGES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 3. GLOBAL SAFETY SYRINGES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 4. GLOBAL SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SAFETY SYRINGES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SAFETY SYRINGES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SAFETY SYRINGES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES SAFETY SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 13. CHINA SAFETY SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SAFETY SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 2. GLOBAL SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 3. GLOBAL SAFETY SYRINGES MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SAFETY SYRINGES MARKET SIZE, BY GLASS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SAFETY SYRINGES MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL SAFETY SYRINGES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL SAFETY SYRINGES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SAFETY SYRINGES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SAFETY SYRINGES MARKET SIZE, BY 6 TO 10 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SAFETY SYRINGES MARKET SIZE, BY 6 TO 10 ML, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SAFETY SYRINGES MARKET SIZE, BY 6 TO 10 ML, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SAFETY SYRINGES MARKET SIZE, BY ABOVE 10 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SAFETY SYRINGES MARKET SIZE, BY ABOVE 10 ML, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SAFETY SYRINGES MARKET SIZE, BY ABOVE 10 ML, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SAFETY SYRINGES MARKET SIZE, BY UPTO 5 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SAFETY SYRINGES MARKET SIZE, BY UPTO 5 ML, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SAFETY SYRINGES MARKET SIZE, BY UPTO 5 ML, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE- DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE- DRUG DELIVERY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE- DRUG DELIVERY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- DRUG DELIVERY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- DRUG DELIVERY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE- IMMUNIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE- IMMUNIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE- IMMUNIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- IMMUNIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- IMMUNIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- IMMUNIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE- INSULIN DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE- INSULIN DELIVERY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE- INSULIN DELIVERY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- INSULIN DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- INSULIN DELIVERY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- INSULIN DELIVERY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE-SAMPLING & DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE-SAMPLING & DIAGNOSTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL SAFETY SYRINGES MARKET SIZE, BY NON-RETRACTABLE-SAMPLING & DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- SAMPLING & DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- SAMPLING & DIAGNOSTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETRACTABLE- SAMPLING & DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL SAFETY SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL SAFETY SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL SAFETY SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL SAFETY SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL SAFETY SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL SAFETY SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL SAFETY SYRINGES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL SAFETY SYRINGES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL SAFETY SYRINGES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL SAFETY SYRINGES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL SAFETY SYRINGES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL SAFETY SYRINGES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL SAFETY SYRINGES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL SAFETY SYRINGES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL SAFETY SYRINGES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. GLOBAL SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 78. GLOBAL SAFETY SYRINGES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 79. GLOBAL SAFETY SYRINGES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. GLOBAL SAFETY SYRINGES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 82. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. GLOBAL SAFETY SYRINGES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. GLOBAL SAFETY SYRINGES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 85. GLOBAL SAFETY SYRINGES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. GLOBAL SAFETY SYRINGES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. GLOBAL SAFETY SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 88. AMERICAS SAFETY SYRINGES MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 89. AMERICAS SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 90. AMERICAS SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 91. AMERICAS SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. AMERICAS SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 93. AMERICAS SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 94. AMERICAS SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 95. AMERICAS SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 96. AMERICAS SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. AMERICAS SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. AMERICAS SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 99. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 101. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 102. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 104. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 105. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 106. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 107. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NORTH AMERICA SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 110. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 112. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 113. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 115. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 116. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 117. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 118. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. LATIN AMERICA SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 140. EUROPE SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. EUROPE SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. EUROPE SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 143. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 144. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 145. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 146. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 148. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 149. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 150. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 151. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. MIDDLE EAST SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 154. AFRICA SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. AFRICA SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 156. AFRICA SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 157. AFRICA SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. AFRICA SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 159. AFRICA SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 160. AFRICA SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 161. AFRICA SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 162. AFRICA SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. AFRICA SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. AFRICA SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 176. GLOBAL SAFETY SYRINGES MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 177. ASEAN SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 178. ASEAN SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. ASEAN SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 180. ASEAN SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. ASEAN SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 182. ASEAN SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 183. ASEAN SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 184. ASEAN SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 185. ASEAN SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. ASEAN SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. ASEAN SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 188. GCC SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 189. GCC SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 190. GCC SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 191. GCC SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. GCC SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 193. GCC SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 194. GCC SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 195. GCC SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 196. GCC SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. GCC SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. GCC SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPEAN UNION SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 210. BRICS SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 211. BRICS SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 212. BRICS SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 213. BRICS SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. BRICS SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 215. BRICS SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 216. BRICS SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 217. BRICS SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 218. BRICS SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. BRICS SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. BRICS SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 221. G7 SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 222. G7 SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 223. G7 SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 224. G7 SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. G7 SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 226. G7 SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 227. G7 SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 228. G7 SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 229. G7 SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. G7 SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. G7 SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 232. NATO SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 233. NATO SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 234. NATO SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 235. NATO SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. NATO SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 237. NATO SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 238. NATO SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 239. NATO SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 240. NATO SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. NATO SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. NATO SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 243. GLOBAL SAFETY SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED STATES SAFETY SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 245. UNITED STATES SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 246. UNITED STATES SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 247. UNITED STATES SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. UNITED STATES SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 249. UNITED STATES SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 250. UNITED STATES SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 251. UNITED STATES SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 252. UNITED STATES SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. UNITED STATES SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. UNITED STATES SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 255. CHINA SAFETY SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 256. CHINA SAFETY SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 257. CHINA SAFETY SYRINGES MARKET SIZE, BY SYRINGE VOLUME, 2018-2030 (USD MILLION)
  • TABLE 258. CHINA SAFETY SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. CHINA SAFETY SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 260. CHINA SAFETY SYRINGES MARKET SIZE, BY IMMUNIZATION, 2018-2030 (USD MILLION)
  • TABLE 261. CHINA SAFETY SYRINGES MARKET SIZE, BY INSULIN DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 262. CHINA SAFETY SYRINGES MARKET SIZE, BY SAMPLING & DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 263. CHINA SAFETY SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. CHINA SAFETY SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. CHINA SAFETY SYRINGES MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)